Linda Muul - Concepedia

Author

Linda Muul

Also Known As

L M Muul, L Muul, L. M. Muul, L. MUUL, L. Muul, LINDA M. MUUL, LINDA MUUL, Linda M Muul, Linda M. Muul, Linda Mesler Muul

Publications

14.1K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Human Genome Research Institute National Cancer Institute National Institute of Neurological Disorders and Stroke National Institute of Allergy and Infectious Diseases

About

Linda Muul is an author at National Institutes of Health specializing in medicine, immunology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	7.1K
2	Cell Biology	12	13	2.7K
3	Health Sciences	3	3	1.7K
4	Allergy	1	1	172
5	Blood Transplantation	1	1	329

Linda Muul

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone Steven A. Rosenberg, Michael T. Lotze, Linda Muul, New England Journal of Medicine Lymphoid NeoplasiaAdvanced CancerCancer ImmunosurveillanceLak CellsProgress Report	1987	2.8K
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer Steven A. Rosenberg, Michael T. Lotze, Linda Muul, New England Journal of Medicine	1985	2.6K
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone Edwin M. Horwitz, Patricia Gordon, Winston K. K. Koo, Proceedings of the National Academy of Sciences Tissue EngineeringCell TherapyAdult Stem CellImmunologyBone Repair	2002	1.6K
T Lymphocyte-Directed Gene Therapy for ADA <sup>−</sup> SCID: Initial Trial Results After 4 Years R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Science	1995	1.5K
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Zvi Ram, Kenneth W. Culver, Eric M. Oshiro, Nature Medicine Neuro-oncologyMedicineViral OncologyGene VectorRadiation Oncology	1997	682
Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. Linda Muul, Paul J. Spiess, E P Director, The Journal of Immunology	1987	485
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials Suzanne L. Topalian, Linda Muul, Diane Solomon, Journal of Immunological Methods Lymphoid NeoplasiaRadiation OncologyTumor ImmunologyImmunotherapy TrialsCancer Immunosurveillance	1987	362
Distinct regulation of interleukin‐17 in human T helper lymphocytes Zhi Chen, Cristina M. Tato, Linda Muul, Arthritis & Rheumatism	2007	359
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates Donald B. Kohn, Michal S. Hershfield, Denise A. Carbonaro, Nature Medicine Cell TherapyTransplantationAutoimmune DiseaseStem Cell TransplantationImmunology	1998	329
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Arie S. Belldegrun, Linda Muul, Steven A. Rosenberg PubMed Antitumor ActivityImmunologyRenal InflammationImmunoeditingImmunotherapy	1988	299

Page 1